Replimune REPL
NASDAQ REPL
$13.00 +0.44 (+3.50%)
At close: Sep 29, 2026 · 4:00 PM EDT

Replimune (REPL) Other Operating Expenses (2021 - 2026)

Updated

Replimune (REPL) reported Other Operating Expenses of -$896,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$895,000 a year earlier.

Analysis

Replimune (REPL) Other Operating Expenses (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Replimune's Other Operating Expenses came in at -$1.79 million; for FY2022 (ended Mar 31, 2022), it came in at -$3.43 million.

  • By fiscal year, Other Operating Expenses came in at -$3.38 million in FY2021.
  • Five-year quarterly Other Operating Expenses spans a low of -$897,000 in fiscal Q2 2026 and a high of -$852,000 in fiscal Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Replimune 1.05 Bn 1.05 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -896,000.00
Sep 30, 2025 -897,000.00
Jun 30, 2025 -895,000.00
Sep 30, 2024 -892,000.00
Jun 30, 2024 -888,000.00
Dec 31, 2022 -859,000.00
Sep 30, 2022 -859,000.00
Jun 30, 2022 -866,000.00
Mar 31, 2022 -874,000.00
Dec 31, 2021 -856,000.00
Sep 30, 2021 -852,000.00
Jun 30, 2021 -849,000.00
API Access

Replimune Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=REPL&period=max&api_key=YOUR_API_KEY